ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2020 and some content may be unavailable. To unlock all content for 2020, please visit the archives.

Abstract: PO2152

The Klotho Deficiency and Not the FGF-23 Rise Is Associated with Heart Failure with Reduced Left Ventricular Ejection Fraction in Patients with Preserved Kidney Function

Session Information

Category: Hypertension and CVD

  • 1403 Hypertension and CVD: Mechanisms

Authors

  • Aloui, Sabra, Department of Nephrology Monastir University, Monastir, Tunisia
  • Lamti, Feten, Department of Nephrology Monastir University, Monastir, Tunisia
  • Letaief, Ahmed, Department of Nephrology Monastir University, Monastir, Tunisia
  • Hamouda, Mouna, Department of Nephrology Monastir University, Monastir, Tunisia
  • Ben salem, Meriem, Department of Nephrology Monastir University, Monastir, Tunisia
  • Ben salah, Manel, Department of Nephrology Monastir University, Monastir, Tunisia
  • Handous, Insaf, Department of Nephrology Monastir University, Monastir, Tunisia
  • Skhiri, Habib, Department of Nephrology Monastir University, Monastir, Tunisia
  • Ferchichi, Salima, Department of Biochemestry F HACHED, Sousse, Tunisia
  • Nouira, Samir, Department of Emergency Medecine, Monastir, Tunisia
Background

The FGF23-Klotho axis is increasingly implicated in the pathophysiology of heart failure, especially during advanced chronic kidney disease (CKD).
Our objective is to study the association between this FGF23-Khloto axis and heart failure in patients without CKD.This topic is less studied in medical literature

Methods

This is a cross-sectional study of the FGF23 assessment, Klotho and the rest of the phosphocalcic assessment covering 70 patients with normal renal function. These patients had echocardiographic exploration which made it possible to distribute them in two groups: Group HF: LVEF(Left Ventricular Ejection Fraction)<55% (n = 18); Group NoHF: LVEF> 55% (n = 52) . Heart failure(HF) was exclusively of ischemic origin.

Results

These were 36 women and 34 men, average age 58 + - 10 years with an estimated glomerular filtration rate (eGFR) at an average of 92 ml / min / 1.73m2. No difference in eGFR between the two groups.
Klotho was far lower with a statistically significant difference in Group HF. FGF23 was higher in Group HF but the difference was not statistically significant.
PTH (parathyroid hormone)was statistically higher in Group HF and calcemia was statistically lower in Group HF.
Phosphatemia and vitamin D were not associated with heart failure.

Conclusion

Although the sample studied is not large, Klotho but not FGF23 is strongly associated with systolic heart failure.This and other results will be further discussed.